CRL Earnings
Charles River Laboratories next reports earnings on August 5, 2026. Track record: 4/4 beats.
Next Earnings In
Wednesday, August 5, 2026
Current Price
$228.22
EPS Estimate
Earnings Per Share
$2.73
-12.4% YoY
Trailing EPS
Last 12 months earnings
-$3.65
Beat Rate
4/4
100%Forward P/E
Price-to-Earnings ratio
18.5
Margin: -4.6%
Analyst Rating
15 analysts
Analyst Sentiment
Buy15 analystsEarnings History
| Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| 2026-03-31 | $1.95 | $2.06 | +5.4% | Beat |
| 2025-12-31 | $2.35 | $2.39 | +1.9% | Beat |
| 2025-09-30 | $2.34 | $2.43 | +3.9% | Beat |
| 2025-06-30 | $2.55 | $3.12 | +22.4% | Beat |
Growth Estimates
| Period | EPS Est. | Revenue Est. | Growth |
|---|---|---|---|
| Current Qtr(0q) | $2.73 | $976.1M | -12.4% |
| Next Qtr(+1q) | $3.05 | $939.2M | +25.5% |
| Current Year(0y) | $11.10 | $3.8B | +8.0% |
| Next Year(+1y) | $12.33 | $3.9B | +11.0% |
Next Quarter Estimates
EPS Estimate
Earnings Per Share
$2.73
Revenue Estimate
$976.1M
Annual EPS Est.
$11.10
+8.0% YoY
CRL Earnings FAQ
When is CRL's next earnings date?
Charles River Laboratories (CRL) is expected to report earnings on August 5, 2026. The consensus EPS estimate is $2.73.
Does CRL usually beat earnings estimates?
Charles River Laboratories has beaten Wall Street EPS estimates in 4 of the last 4 quarters (100% beat rate).
What is CRL's trailing EPS?
Charles River Laboratories's trailing twelve-month EPS is -$3.65. This is calculated from the last four quarters of reported earnings.
What do analysts think about CRL?
15 Wall Street analysts cover Charles River Laboratories. The consensus rating is "Buy" with an average price target of $230.93, implying 1.2% upside from the current price.